this therapy is both the logical and indispensable outcome of using these agents to treat human infections (Mahmoud and Rice 1999; Ternent et al. 2014) .
Resistance developed by the bacteria against antibiotics is described as the talent of bacteria to resist the effects of antibiotics generated either to eradicate or control them (Arya 2007) . The release of each new class of antibiotics for treatment, shortly after, has been followed by the emergence of new strains of bacteria which are resistant to this class (Butler and Buss 2006; Clatworthy et al. 2007; Lewis 2013) . In this respect, developing new treatment strategies for bacterial infections is very important (Mondragón et al. 2014) .
According to its properties, antibiotics has the bacteriostatic action to stop the growth of bacteria and bactericidal action to wipe out the bacteria. However, the distinction between these properties is not explicit, as it depends on the drug concentration used and the type and the growth stage of bacteria (Zhang 2009 ). Hence, multiple antibiotic therapy is a more appropriate form of treatment.
In fact, the bacterial infection is a complicated process for both the infectious bacteria and the host (Carvalho et al. 2012) . It is suggested that a significant role in the progress of infections is basically played by the immune system (Linares and Martinez 2005) . The immune system is expressed as a system of biological structures and processes in an organism protecting the body from likely harmful substances via recognizing and responding to antigens (Alberts et al. 2002) . In this context, the reactions of different hosts against the same infection can be different due to immune system's response given by host.
In light of the above, dynamics of relations among antibiotics, immune system's cells and bacteria are important to understand the nature of the infection.
Mathematical models are one of the significant tools used in both analyzing the spread of infectious diseases in a population of individuals (Hethcote 2000; Singer 1984) , and predicting the timing and expansion of infection and possible reinfection processes in an individual (Mohtashemi and Levins 2001) . While the former is usually used for planning, prevention and control scenarios, the latter can be active in therapy/intervention programs for treating the individuals exposed to the particular pathogen. In this respect, understanding and anticipating the time of occurrence and magnitude of the maximum load of the bacteria and immune system cells by mathematical modelling can be crucial in selecting effective intervention strategies (Whitman and Ashrafiuon 2006) .
Consequently, results on reproduction of sensitive and resistant bacteria to antibiotics are obtained in Austin et al. (1997) , Bonten et al (2001) , Esteva et al. (2011 ), Wiesch et al. (2011 ), Zhang (2009 ; definitions of factors responsible for resistance prevalence are studied in Austin and Anderson (1999) , Linares and Martinez (2005) , Opatowski et al. (2011) , Rodrigues et al. (2007) ; bacteria behavior under different antibiotic treatments is examined in Alavez et al. (2006) , Bonhoeffer et al. (1997) , Bootsma et al. (2012 ), D' Agata et al. (2007 , Sun et al. (2010) ; optimization results and design of control measures are investigated in Bonten et al. (2001) , Haber et al. (2010) , Massad et al. (2008) , Sotto and Lavigne (2012) ; biological cost and persistence of antibiotic resistance are analyzed in Andersson et al. (2001) , Andersson and Levin (1999) , Antia et al. (1996) , Johnson and Levin (2013) , Mondragón et al. (2014) ; dynamics between pathogens and immune response are given in André and Gandon (2006) , Carvalho et al. (2012 ), D'Onofrio (2005 , Gilchrist and Coombs (2006) , Gilchrist and Sasaki (2002) , Kostova (2007) , Mohtashemi and Levins (2001) , Nowak and May (2000) , Whitman and Ashrafiuon (2006) , respectively.
In this study, we have constructed a continuous time model considering the immune response of the host and the basic mechanisms of bacterial resistance to antibiotics. Our aim is to find specific parameters determining the change in the concentrations of the immune system's cells produced in host to fight these and the sensitive sub-populations and resistant sub-populations that has either arisen through random mutation and clonal enlargement or through cross-contamination in a special infection and under a appropriate treatment regimen.
Model formulation
When the emergence of resistant bacteria to antibiotic has modelled, there are the two basic aspects generally considered. These are within-host models and within-hospital compartmental models. Within-hospital compartmental models are generally SIR models in epidemiology, considering especially how infections will expand throughout the hospital (Ternent et al. 2014 ). These models are useful to develop strategies to prevent the spread of resistant individuals to antibiotic in hospital.
Current mathematical models focusing on the fact that it is within the host that resistance develops, aim to study how antibiotic treatment strategies can affect, and in addition, how the occurrence of antibiotic resistance can be prevented (Alberts et al. 2002; Hethcote 2000) . In such models, the effect of immune cells generated by the host under the pressure of the bacteria are frequently either neglected or assumed to be at a constant rate. We built up the mathematical model including cell-mediated immune response. In addition, treatment regimens involving multiple antibiotic have been used in most bacterial infections due to bacterial resistant. In this sense, besides the interaction of bacterial-immune response, to investigate the effects of multiple drug therapy is biological more meaningful.
We analyzed the concentrations of the immune cells and bacteria in an individual receiving a cocktail of multi-drug treatment against bacteria via mathematical modelling. Let us denote by S(t) and R(t) the population sizes of sensitive and resistant bacteria against multiple antibiotics at time t, respectively, by B(t) population sizes of immune cells at time t, and by A i (t) the concentration of the i-th antibiotic, for i = 1, 2, …, n at time t. The parameters used in the model are as follows.
We assume that bacteria follow a logistic growth with carrying capacity T. Let β S and (1 − c)β S the birth rate of sensitive and resistant bacteria, respectively. Specific mutations arising from resistance to chemical control frequently have an inherent fitness cost which may be resulted through reduced reproductive capacity or competitive ability (Alavez et al. 2006) . We evaluate fitness cost as a reduction on the reproduction rate of the resistant strain, therefore 0 < c < 1. Likewise, we have supposed that using a logistic style term, immune cells are recruited to the region of infection at a rate k and carrying capacity of these is as ω fold of amount of present bacteria. This is biologically very significant in terms of proliferation of specific immune cells. Also, these interacts can be expressed as a generalised model of a local bacterial infection, such as a urinary tract, tuberculosis or wound infection. During the administration of the i th antibiotic, a number of resistant bacteria to it can be showed up due to mutations of exposed sensitive bacteria to such antibiotic, we model this situation by the term α i A i S where α i is the mutation rate of sensitive bacteria due to exposure to i th antibiotic. Sensitive and resistant bacteria have per capita death rates by response of immune cells and this rates is λ. Sensitive bacteria also die due to the action of the antibiotics, and we have assumed that this situation in model is by the term d i A i S, where d i is the death rate of sensitive bacteria due to exposure to i-th antibiotic. Lastly, the i-th antibiotic concentration is supplied at a constant rate δ i , and is taken up at a constant per capita rate μ i . Under the assumptions a fore mentioned, we obtain the following system of (n + 3) ODE's:
where To reduce the number of parameters, the variables are changed as follows;
With the new variables, the normalized system is given as;
, β R = (1 − c)β S and η = ωT. The biologically studied region is given by the set
The following proposition ensures that system (3) is well posed in the sense that the solutions with positive initial conditions started in Ω remain in this region for all t ≥ 0, and so, this solutions of system (3) have biological meaning.
Proposition 1 The region Ω defined in (4) is positively invariant with respect to the system (3).
Proof By adding the first two equations of the system (3), is obtained. Considering the region Ω, we have the following inequality;
By the solution according to (s + r) of inequality (6), it follows that 0 ≤ s + r ≤ 1 for all t ≥ 0. Furthermore, the solutions of the last n equations of system (3) 
Hence, the vector field of system (3) restricted to the boundary of Ω does not include a point at the exterior of it. In this context, solutions starting in Ω + remain in the region Ω for all t ≥ 0.
Qualitative analysis of system (3)
We have examined the existence and stability of equilibria of system (3).
Proposition 2 Let
We accept that the general expressions of the system's equilibria show as E j = s,r,b, a i for i = 1, 2, . . . , n and j = 0, 1, 2, 3. Then, system (3) always has E 0 = (0, 0, 0, 1, 1, …, 1) (namely, the infection-free equilibrium point), E 1 = (0, 1, 0, 1, 1, …, 1), E 2 = (0, B, B, 1, 1, …, 1) contained in Ω. When A > B, in addition to E 0 , E 1 and E 2 , there exists a fourth the equilibrium point,
Proof In (9), it is clear that
The equilibria of system (3) are given by the solutions of the system of following algebraic equations;
From the last n equation of system (11), we have a i = 1 for i = 1, 2, …, n. Consequently, the system (11) turns into following system; From (12), it is obtained that either b = 0 or b =s +r.
• When b = 0, we have that the equilibrium points are E 0 = (0, 0, 0, 1, . . . , 1), E 1 = (0, 1, 0, 1, . . . , 1) and Although the equilibrium points E 0 and E 1 always exist in Ω, the equilibrium point E I where signs of s and r are opposite, is biologically meaningless. Therefore, E I is not in Ω.
• In case of b =s +r, it is obtained the equilibrium points as following;
, 1, . . . , 1 .
Equilibrium point E 2 always exists in Ω. In addition that, the equilibrium point E 3 is in Ω, when
(12)
Taking (9) into account, we have that equilibria of system (3) This criteria has given necessary and sufficient conditions for all of the roots of the characteristic polynomial (with real coefficients) to lie in the left half of the complex plane (Allen 2007) . , that is, the determinants of all of the Hurwitz matrices are positive, det H j > 0, j = 1, 2, . . . , n, then the equilibrium X is locally asimptotically stable. If det H j < 0, for some j = 1, 2, . . . , n, then the equilibrium X is unstable (Allen 2007 ).
Theorem 4 Suppose
The following proposition is shown conditions that equilibrium points in the Proposition 2 are locally asimptotically stability (LAS). P( ) = n + a 1 n−1 + · · · + a n−1 + a n ,
: a 1 , a 3 > 0 and a 1 a 2 > a 3 , n = 4 : a 1 , a 3 , a 4 > 0 and a 1 a 2 a 3 > a 2 3 + a 2 1 a 4 , n = 5 : a 1 , a 2 , a 3 , a 4 , a 5 > 0, a 1 a 2 a 3 > a n + a 1 n−1 + a 2 n−2 + · · · + a n−1 + a n = 0,
Proposition 4
The equilibrium points of system (3) in Ω satisfy
Proof For the stability analysis, the functions of the right side of system (3) are determined as follows;
That jacobian matrix obtained from the equations in (14) is For ease of examination, the τ-th eigenvalue of equilibrium point E k has shown as λ k,τ for k = 0, 1, 2, 3 and τ = 1, 2, . . . , n + 3, n ∈ N.
(i) Some of the eigenvalues evaluated at the equilibrium point E 0 in Ω are
The eigenvalue λ 0,2 is positive, due to (2). According to Theorem 4, the infection-free equilibrium point E 0 is unstable point for system (3). In the same way, the eigenvalues for E 1 in Ω are that 1,1 = − n i=1 (α i + d i ), λ 1,2 = −β R , λ 1,3 = k and λ 1,i+3 = −μ i for i = 1, 2, …, n. The eigenvalue λ 1,3 is positive, due to (2). From Theorem 4, E 1 is unstable point for system (3).
(ii) The jacobian matrix in (15) evaluated at the equilibrium point E 2 in Ω is given below (14)
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where matrix J B(E 2 ) is the block matrix of (16). From (2), it is clear that Reλ 2,i+3 < 0. Characteristic equation of (17) is By the solution of (18), these eigenvalues are determined. Hence, it is obtained that and λ 2,2 and λ 2,3 are gained by solving following equation, It can be observed that (k + β R B), kβ R > 0, due to (2) and (10). From Theorem 3 (n = 2), Re 2,2 and Re 2,3 < 0. According to Theorem 4, the LAS conditions for E 2 are provided for the eigenvalues, 2,i+3 , 2,2 and 2,3 , exceptionally λ 2,1 in the (19). It is sufficient to examine the sign of λ 2,1 . By (9), (19) it can be rewrited as λ 2,1 = (β S + η)(A − B). In this respect, λ 2,1 is negative, when A < B.
As a result, the equilibrium point E 2 is LAS for system (3), when A < B. (iii) Let B < A. Then the equilibrium point E 3 is revealed in Ω. The Jacobian matrix for E 3 is where The eigenvalues obtained from (21) are λ 3,i+3 = −μ i for i = 1, 2, …, n and the remaining three eigenvalues, λ 3,1 , λ 3,2 and λ 3,3 , are found from following matrix;
where the matrix J B(E 3 ) is the block matrix of (21). By (2), it is Reλ 3,i+3 < 0. Characteristic equation of matrix (23) is obtained as follows:
We have a 1 , a 3 > 0 due to (2) and (22). By (25), we have that and so, Therefore, it is obtained that a 1 a 2 − a 3 > 0 due to (2) and (22). From Theorem 3(n = 3), Reλ 3,1 , Reλ 3,2 and Reλ 3,3 < 0. According to Theorem 4, The equilibrium point E 3 in Ω is LAS for the system (3), when it exists biological, that is, B < A. Hence, proof is completed.
The LAS conditions found for equilibrium points in (13) are summarized in the Table 1 .
=0
Proposition 6 Let us denote by Γ 2 the LAS region of the equilibrium point E 2 in Ω. In the same way, Γ 3 is for E 3 . Then Γ 2 ∩ Γ 3 = ∅.
Proof It can be clearly observed in Table 1 .
The parameter values and it's references used for numerical study are given in Table 2 .
Proposition 7 If A < B, then the equilibrium point E 2 = (0, B, B, 1, …, 1) is globally asimptotically stable (GAS) in Ω.
Proof Their solutions approach a i = 1 for i = 1, 2, …, n, when last n equations of system (3) are considered separately. Replacing s = 0 and a i = 1 for i = 1, 2, …, n in system Table 1 Existence and stability conditions of the equilibria of system (3)
Where the values A, B and C are as indicated in (9) Equilibrium points Biological existence conditions LAS conditions
Always exists Unstable Esteva et al. (2011) (3), we attain the asymptotically equivalent planar system (Mondragón et al. 2014) 
According to the Dulac criterion, there exists a continuously differentiable Dulac function Φ(r, b) for a simply connected region Ω 1 ⊂ R 2 such that Since (f(r, b), g(r, b) ) is the vector field of system (26),
This result reveals that system (26) has no periodic orbits contained in the interior of Ω 1 in compliance with Dulac-Bendixon criterion. In addition, the region Γ 2 cited in the Proposition 6 does not include another the LAS equilibrium point. Thus, by the Poincaré-Bendixon Theorem and Dulac-Bendixon criterion, we have that equilibrium point E 2 = (0, B, B, 1, …, 1) is GAS. For status (i) obtained from the Table 2 , the qualitative analysis of the system (2) has supported by numerical simulations in the following Figs. 1, 2 and 3. Here, it is shown that the equilibrium point E 2 is GAS. Also, as a result of using multiple antibiotics at least for 60 days, sensitive bacteria is removed and resistant bacteria and immune cells have same equilibria value of , then equilibrium point E 3 is GAS in the region
Proof If the last n equations of system (3) are separated, then their solutions approach a i = 1 for i = 1, 2, . . . , n. Replacing these values in the first three equations of system (3), we attain the following: in the region (29). Considering (9), then the system (30) transforms to where σ = β S β S +η . Also, it is clear that σ > A. In this context, the GAS of equilibrium point E 3 can be obtained by applying the LaSalle-Lyapunov Theorem. Lyapunov function is where c 1 , c 2 and c 3 are arbitrary positive constants and s, r and b are in (22). Differentiating V (s, r, b) with respect to t, we get Let 1 −r < s. In this case, since 0 < 1 − (s +r) < s −s and 1 −r + r < s + r < 1, it is obtained that respectively. In addition, if
By ( , then equilibrium point E 3 is GAS for system (31) in Ω 2 , and so, for system (3) in Ω. Proposition is proved.
For status (ii) obtained from the Table 2 , the qualitative analysis of the system (3) has supported by numerical simulations in Fig. 4 . In this case, it is found that E 3 is GAS. Moreover, sensitive and resistant bacteria to multiple antibiotics and immune system cells have positive equilibrium values as in E 3 .
Conclusions
In this paper, we formulated a mathematical model of bacterial resistance to immune system response and multiple antibiotics simultaneously, considering specific changes in bacterial DNA sequence as the only mechanism of bacterial resistance acquisition in order to evaluate the effectiveness of antibiotic treatments with respect to the mechanism above.
The parameter A is interpreted as the number of bacteria produced by the fraction of sensitive bacteria that survive to the effects due to antibiotics and immune cells. Similarly, the parameter B represents the bacteria produced by resistant bacteria. Also, the parameter η is expresses as effect of immune cells on the bacteria .
Our model is quite appropriate when compared to the complexity of biological phenomenon and it predicts in terms of the parameters A and B when the bacterial progression is either for resistant bacteria and immune cellsas shown in Figs. 1, 2 and 3 or for sensitive and resistant bacteria and immune cells as shown in Fig. 4 .
The model suggests that if sensitive bacteria can infect but do not produce sufficient progeny (in case of A < B) then they can be removed and resistant bacteria continue to survive in balance with the immune cells in the host. When sensitive bacteria persist, the model predicts the scenario that the immune response of host and antibiotics is not (36) s −s s ds dt < 0, r −r r dr dt < 0.
Fig. 4
In case of (ii) in the Table 2 , time-dependent changes of all the variables enough to eliminate them (in case of A > B), and therefore both types of bacteria continue to survive and coexist in balance with the immune cells in the host. According to the results of this analysis, the infection never disappears. Also, the infection is continued by resistant bacteria, when the appropriate antibiotics are used, otherwise sensitive and resistant bacteria. The magnitude of infection depends on the effect of immune system in the first case and multiple antibiotics and immune system in the second case.
These results in our model highlight the fact that those whose immunity response against infections have diminished, suffer from the same bacterial infections more. Furthermore, this model shows that some of the bacterial infections believed to be limited or destroyed, make an individual whose immune system deteriorated suffer more.
Additionally, the results obtained from numerical studies in terms of bacterial infection reveal the affinity substantially with reference to the clinical treatment.
For future work we are planing consider other mechanisms such as the loss of resistance in the resistant bacteria and gaining resistance by conjugation of sensitive and resistant bacteria in order to get more accurate results.
